BCK Capital Management’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-265,000
Closed -$737K – 107
2022
Q3
$737K Buy
+265,000
New +$643K 0.53% 41

BCK Capital Management's ZY Position: Q4 2022 in Review

BCK Capital Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 265,000 shares — an estimated $737K sold.

BCK Capital Management first reported a position in ZY in Q3 2022 and held it in 1 quarter. The position peaked at $737K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • BCK Capital Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BCK Capital Management sold 265,000 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $737K.
  • BCK Capital Management first reported a position in Zymergen Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • BCK Capital Management's Zymergen Inc. Common Stock position peaked at $737K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on BCK Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.